Patents Assigned to Molecular Rx, Inc.
  • Method and composition for the treatment of disorders involving immunological dysfunction
    Patent number: 5846532
    Abstract: A method and composition are provided for treatment of disorders involving immunological dysfunction. The invention comprises the administration of a low level of ribonucleotide polymerase protein or a derivative thereof to a human or animal with an immune dysfunction disorder.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 8, 1998
    Assignee: Molecular Rx, Inc.
    Inventor: Ellis L. Kline
  • Method and composition for treatment of disorders involving immunological dysfunction
    Patent number: 5804188
    Abstract: A method and composition are provided for treatment of disorders involving immunological dysfunction. The invention comprises the administration of a low level of ribonucleotide polymerase protein or a derivative thereof to a human or animal with an immune dysfunction disorder.
    Type: Grant
    Filed: March 29, 1995
    Date of Patent: September 8, 1998
    Assignee: Molecular Rx, Inc.
    Inventor: Ellis L. Kline
  • Method and composition for the treatment of a individual infected with an immunodeficiency virus
    Patent number: 5736133
    Abstract: A method and composition are provided for treatment of herpes related disorders. The invention comprises the administration of a low level of neuraminidase protein or a derivative thereof. The method is particularly effective in treating herpes related disorders such as shingles, cold sores, herpes lesions in general and chronic fatigue syndrome.
    Type: Grant
    Filed: September 19, 1996
    Date of Patent: April 7, 1998
    Assignee: Molecular Rx, Inc.
    Inventors: Ellis L. Kline, Walter W. McAlhaney
  • Assay and treatment for demyelinating diseases such as multiple sclerosis, related hybridomas and monoclonal antibodies
    Patent number: 5645997
    Abstract: The present invention relates to the diagnosis of multiple sclerosis. More specifically, this invention relates to an assay for detecting antigen(s) associated with multiple sclerosis. The present invention also relates to the generation of hybridomas which produce monoclonal antibodies which are specific for the multiple sclerosis-associated antigens. The present invention's use is in diagnosing multiple sclerosis and in routine follow-up monitoring of multiple sclerosis patients as to disease progression or response to therapy.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 8, 1997
    Assignees: Molecular Rx, Inc., Cell Med, Inc.
    Inventors: Ellis L. Kline, Daniel H. Zimmerman
  • Method for treatment of herpes virus infections
    Patent number: 5558863
    Abstract: A method and composition are provided for treatment of herpes virus infections. The invention comprises the administration of a low level of neuraminidase protein or a derivative thereof.
    Type: Grant
    Filed: February 21, 1995
    Date of Patent: September 24, 1996
    Assignee: Molecular Rx, Inc.
    Inventors: Ellis L. Kline, Walter W. McAlhaney
  • Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
    Patent number: 4966753
    Abstract: A method and composition for treating malignant neoplasia and acquired immune deficiency syndrome by once daily administration of a substance (such as human chorionic gonadotropin) characteristic of the tumor or acquired immune deficiency syndrome-afflicted cell in an amount less than the lowest amount necessary to provoke a humoral immune response, as exemplified by the existence of a negative wheal upon subcutaneous administration.
    Type: Grant
    Filed: June 16, 1989
    Date of Patent: October 30, 1990
    Assignee: Molecular Rx, Inc.
    Inventor: John McMichael